Spots Global Cancer Trial Database for Glucose Monitoring to Predict and Treat High Glucose Levels After Steroid Treatment
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Glucose Monitoring to Predict and Treat High Glucose Levels After Steroid Treatment
Official Title: Continuous Glucose Monitoring For Prediction and Treatment of Steroid-Induced Hyperglycemia
Study ID: NCT04210128
Interventions
Study Description
Brief Summary: The purpose of this study is to see if continuous glucose monitoring can identify how often people who have pre-diabetes or medical obesity or well-controlled diabetes experience very high glucose values while receiving chemotherapy for breast cancer or pancreatic.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact Details
Name: James Flory, MD
Affiliation: Memorial Sloan Kettering Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
